SM

Stelinpullamkottu Mathai

Active Director Managing Director DIN 02987904
DIN 02987904 First appointment Apr 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Apr 2010
Shareholding value •••• Premium profile

About Stelinpullamkottu Mathai

Data last updated:

Stelinpullamkottu Mathai is a Managing Director at Renauxe Pharma India Private Limited (since 2010), Director at Biocent Scientific India Private Limited (since 2016) and Director at Westler Lifescience India Private Limited (since 2018). The companies operate in Pharma, Chemicals and Trading. The 3 current companies with reported revenue have a combined latest revenue of ₹16.63 Cr; the largest is Renauxe Pharma India Private Limited at ₹12.66 Cr (FY 2023). Earlier, Stelinpullamkottu Mathai was a Director at Lifio Bio-Science India Private Limited (2016–2021) and Director at Tertiary Care Private Limited (2020–2021).

DIN 02987904
Primary Designation Managing Director
Industry Pharma
First Appointment 07 Apr 2010
Oldest Company Age 16 yrs
Largest company Renauxe Pharma India Private Limited · ₹12.66 Cr (FY 2023)
Combined revenue ₹16.63 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Renauxe Pharma India Private Limited U21002KL2010PTC025811
Managing Director07 Apr 20102010₹12.66 Cr (FY 2023)Active
Director11 Nov 20162016₹3.53 Cr (FY 2025)Active
Director21 Nov 20182018₹43.9 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Sep 20162016₹5.2 Lakh (FY 2022)Active
Tertiary Care Private Limited U85100KL2020PTC063568
Director12 Aug 20202020₹88,731 (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Stelinpullamkottu Mathai

Directorship timeline

Open interactive timeline →
Westler Lifescience India Private Limited
Renauxe Pharma India Private Limited
Biocent Scientific India Private Limited
Lifio Bio-Science India Private Limited
Premium access

Shareholding and investment profile for Stelinpullamkottu Mathai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Stelinpullamkottu Mathai

Stelinpullamkottu Mathai currently holds 3 directorships: Renauxe Pharma India Private Limited (Managing Director, since 07 Apr 2010, revenue ₹12.66 Cr (FY 2023)); Biocent Scientific India Private Limited (Director, since 11 Nov 2016, revenue ₹3.53 Cr (FY 2025)); Westler Lifescience India Private Limited (Director, since 21 Nov 2018, revenue ₹43.9 Lakh (FY 2025)).

Stelinpullamkottu Mathai was first appointed on 07 Apr 2010 as Managing Director at Renauxe Pharma India Private Limited. The most recent appointment on record is 12 Aug 2020 at Tertiary Care Private Limited.

The 3 current companies of Stelinpullamkottu Mathai that report revenue have a combined latest revenue of ₹16.63 Cr: Renauxe Pharma India Private Limited ₹12.66 Cr (FY 2023); Biocent Scientific India Private Limited ₹3.53 Cr (FY 2025); Westler Lifescience India Private Limited ₹43.9 Lakh (FY 2025).

Stelinpullamkottu Mathai held 2 earlier board appointments: Lifio Bio-Science India Private Limited (Director, 27 Sep 2016 to 10 Mar 2021); Tertiary Care Private Limited (Director, 12 Aug 2020 to 01 Jun 2021).

The current boards of Stelinpullamkottu Mathai's companies include Aleyamma Mathai (Renauxe Pharma India Private Limited), Preeti Mathew (Renauxe Pharma India Private Limited), Vijo Thomas (Biocent Scientific India Private Limited), Jobi Cherian (Westler Lifescience India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available